Apr 14, 2015
2:1
For every share held, investors received 2. The price per share adjusted from $56.95 to $28.48.
The split itself did not change the total investment value.
Hybio Pharmaceutical Co., Ltd. Class A (SZSE:300199) operates in the Pharmaceuticals: major industry.
Hybio Pharmaceutical Co., Ltd. Class A company overviewHybio Pharmaceutical Co., Ltd. Class A's most recent stock split was on April 14, 2015. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
Hybio Pharmaceutical Co., Ltd. Class A (SZSE:300199) has split its stock 3 times: a 2-for-1 split on May 17, 2012, a 2-for-1 split on April 26, 2013, and a 2-for-1 split on April 14, 2015.
Hybio Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between May 17, 2012 and April 14, 2015.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hybio Pharmaceutical Co., Ltd. Class A's 2-for-1 split on April 14, 2015, every share became 2 shares.
Hybio Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on April 14, 2015, 11 years ago. Companies announce splits in advance, and any new SZSE:300199 split will appear on this page.
Already premium?